- Home
- DYN vs CPF Comparison
DYN vs CPF Comparison
Compare DYN & CPF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DYN
- CPF
- Stock Information
- Founded
- DYN 1984
- CPF 1954
- Country
- DYN United States
- CPF United States
- Employees
- DYN N/A
- CPF N/A
- Industry
- DYN Medicinal Chemicals and Botanical Products
- CPF Major Banks
- Sector
- DYN Health Care
- CPF Finance
- Exchange
- DYN Nasdaq
- CPF Nasdaq
- Market Cap
- DYN 848.8M
- CPF 681.5M
- IPO Year
- DYN 2020
- CPF N/A
- Fundamental
- Price
- DYN $10.78
- CPF $26.39
- Analyst Decision
- DYN Strong Buy
- CPF Buy
- Analyst Count
- DYN 12
- CPF 1
- Target Price
- DYN $47.73
- CPF $30.00
- AVG Volume (30 Days)
- DYN 2.8M
- CPF 166.2K
- Earning Date
- DYN 05-05-2025
- CPF 04-23-2025
- Dividend Yield
- DYN N/A
- CPF 4.07%
- EPS Growth
- DYN N/A
- CPF 4.40
- EPS
- DYN N/A
- CPF 2.14
- Revenue
- DYN N/A
- CPF $247,703,000.00
- Revenue This Year
- DYN N/A
- CPF N/A
- Revenue Next Year
- DYN N/A
- CPF $6.49
- P/E Ratio
- DYN N/A
- CPF $12.40
- Revenue Growth
- DYN N/A
- CPF 5.36
- 52 Week Low
- DYN $6.36
- CPF $19.46
- 52 Week High
- DYN $47.45
- CPF $33.25
- Technical
- Relative Strength Index (RSI)
- DYN 57.30
- CPF 54.40
- Support Level
- DYN $7.38
- CPF $24.78
- Resistance Level
- DYN $8.01
- CPF $25.31
- Average True Range (ATR)
- DYN 0.91
- CPF 1.14
- MACD
- DYN 0.44
- CPF 0.25
- Stochastic Oscillator
- DYN 92.47
- CPF 72.91
About DYN Dyne Therapeutics Inc.
Dyne Therapeutics Inc is a clinical-stage neuromuscular disease company focused on discovering and advancing life-transforming therapeutics for people living with genetically driven neuromuscular diseases. Its FORCE platform develops targeted therapeutics that are designed to overcome limitations in delivery to muscle tissue and the central nervous system, or CNS. Its FORCE platform therapeutics consist of a payload that is rationally designed to target the genetic basis of the disease are seeking to treat, a linker, and an antigen-binding fragment, that attaches to the payload using the linker. Its Pipeline includes DYNE-101, DYNE-251, DYNE-302, and DYNE-401.
About CPF Central Pacific Financial Corp New
Central Pacific Financial Corp operates in the financial services sector in the United States. It is a full-service commercial bank offering a broad range of banking products and services, including accepting time and demand deposits and originating loans. Bank's deposits are insured by the Federal Deposit Insurance Corporation (FDIC) up to applicable limits. The bank is not a member of the Federal Reserve System. The company's loans include commercial loans, construction loans, commercial and residential mortgage loans, and consumer loans. The company derives income from interest and fees on loans, interest on investment securities, and fees received in connection with deposits and other services.